Back

Reevaluating the long-term efficacy of primary prophylactic implantable cardioverter-defibrillators for sudden cardiac death in the era of advanced heart failure treatment

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Ventricular arrhythmias Risk Factors and Risk Assessment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)

9 More presentations in this session

Presentation thumbnail
Discussant - Ventricular arrhythmias
Presentation thumbnail
Influence of minimized atrial pacing on risk of ventricular arrhythmias in patients with pacemakers due to sinus node dysfunction
Mr F. Mikkelsen (Risskov, DK)
Abstract
Presentation thumbnail
Sex differences in indications, complications and outcomes of de novo implantable cardioverter defibrillator and cardiac resynchronization therapy: with a focus on diabetes status
Miss Y. Zhou (Stockholm, SE)
Abstract Video
Presentation thumbnail
Wearable cardioverter-defibrillator compared to beta blockers in patients at risk of sudden death: a real-world propensity score-matched study.
Professor L. Fauchier (Tours, FR)
Abstract Video
Presentation thumbnail
Prognostic comparison between implantable cardioverter-defibrillator and amiodarone in cancer patients
Mr H. Kida (Osaka, JP)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Ventricular arrhythmias

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources